NeoGenomics (NEO) Tops Q2 EPS by 1c

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $67.7 million versus the consensus estimate of $66.18 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• BMO Capital Starts Carter's (CRI) at Outperform
• Barnes & Noble Education (BNED) Tops Q1 EPS by 12c